BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 17625308)

  • 61. Prophylactic octreotide administration does not prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Zou DW; Li ZS
    Pancreas; 2008 Oct; 37(3):241-6. PubMed ID: 18815543
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.
    Arvanitidis D; Anagnostopoulos GK; Giannopoulos D; Pantes A; Agaritsi R; Margantinis G; Tsiakos S; Sakorafas G; Kostopoulos P
    J Gastroenterol Hepatol; 2004 Mar; 19(3):278-82. PubMed ID: 14748874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
    Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
    Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Does allopurinol prevent post endoscopic retrograde cholangio- pancreatography pancreatitis? A randomized double blind trial.
    Abbasinazari M; Mohammad Alizadeh AH; Moshiri K; Pourhoseingholi MA; Zali MR
    Acta Med Iran; 2011; 49(9):579-83. PubMed ID: 22052140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kubiliun NM; Elmunzer BJ
    Gastrointest Endosc Clin N Am; 2013 Oct; 23(4):769-86. PubMed ID: 24079789
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate.
    Chang JH; Lee IS; Kim HK; Cho YK; Park JM; Kim SW; Choi MG; Chung IS
    Gut Liver; 2009 Sep; 3(3):205-10. PubMed ID: 20431747
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
    Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
    Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Meta-analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis.
    Bai Y; Gao J; Zhang W; Zou D; Li Z
    Aliment Pharmacol Ther; 2008 Sep; 28(5):557-64. PubMed ID: 18714440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis.
    Fluhr G; Mayerle J; Weber E; Aghdassi A; Simon P; Gress T; Seufferlein T; Mössner J; Stallmach A; Rösch T; Müller M; Siegmund B; Büchner-Steudel P; Zuber-Jerger I; Kantowski M; Hoffmeister A; Rosendahl J; Linhart T; Maul J; Czakó L; Hegyi P; Kraft M; Engel G; Kohlmann T; Glitsch A; Pickartz T; Budde C; Nitsche C; Storck K; Lerch MM
    BMC Gastroenterol; 2013 Jan; 13():11. PubMed ID: 23320650
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
    Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
    Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review.
    Kubiliun NM; Adams MA; Akshintala VS; Conte ML; Cote GA; Cotton PB; Dumonceau JM; Elta GH; Fogel EL; Freeman ML; Lehman GA; Naveed M; Romagnuolo J; Scheiman JM; Sherman S; Singh VK; Elmunzer BJ;
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1231-9; quiz e70-1. PubMed ID: 25579870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis.
    Zhu K; Wang JP; Su JG
    Exp Ther Med; 2017 Oct; 14(4):3036-3056. PubMed ID: 28966682
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis.
    Lyu Y; Wang B; Cheng Y; Xu Y; Du W
    Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):426-432. PubMed ID: 31490455
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double-blind placebo controlled trial.
    Shah TU; Liddle R; Branch MS; Jowell P; Obando J; Poleski M
    JOP; 2012 Sep; 13(5):514-8. PubMed ID: 22964958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of gabexate mesylate in Italian hospitals: a multicentre observational study.
    Pelagotti F; Cecchi M; Messori A;
    J Clin Pharm Ther; 2003 Jun; 28(3):191-6. PubMed ID: 12795778
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prospective, randomized, double-blind, placebo-controlled trial of ulinastatin for prevention of hyperenzymemia after double balloon endoscopy via the antegrade approach.
    Itaba S; Nakamura K; Aso A; Tokunaga S; Akiho H; Ihara E; Iboshi Y; Iwasa T; Akahoshi K; Ito T; Takayanagi R
    Dig Endosc; 2013 Jul; 25(4):421-7. PubMed ID: 23368820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.